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ABSTRACT 
OBJECTIVE: The objective of this selective EBM review is to determine if there is a statistically 
significant difference in using combination therapies that include cryotherapy vs. cryotherapy 
alone in the clearance of genital/anogenital warts. 
STUDY DESIGN: Systematic review of three peer reviewed primary studies that were published 
between 2009-2014. 
DATA SOURCES: Review of a double-blind placebo-controlled study, a single-blinded 
randomized controlled study, and a randomized clinical comparative study from 2011. All 
sources were selected from PubMed based on the applicability to the clinical question and how 
accurately they answered the question regarding the patient population 
OUTCOMES: The outcomes of investigation were POEMs (Patient-Oriented Evidence that 
Matters) that measured the overall level of clearance and partial clearance of warts.  
RESULTS: On et al., showed that after 17 weeks of therapy, the combination therapy of 
sinecatechins 15% ointment plus cryotherapy achieved 71% partial clearance vs. 52% on 
cryotherapy alone with a p-value of 0.2037. Gilson et al., at week 4, saw a 60% clearance with 
the combination of podophyllotoxin cream plus cryotherapy vs. 45% clearance of cryotherapy 
alone; although, these results weren’t considered statistically significant and by week 24 the 
clearance rate of either therapy was the same. Mi et al., showed a 32% clearance of anogenital 
warts with both the ALA-PDT plus cryotherapy and cryotherapy alone. It also showed a 94% 
clearance of genital warts with the combination therapy and a 50% clearance with the 
cryotherapy alone. 
CONCLUSIONS: In two of the three studies, it showed that there is a statistically significant 
improvement when using the combination therapies, specifically the combination of 
sinecatechins 15% ointment plus cryotherapy and the combination of ALA-PDT plus 
cryotherapy.  
KEYWORDS: anogenital warts, genital warts, cryotherapy 
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INTRODUCTION 
 Human papilloma virus (HPV) is a sexually transmitted disease that only infects humans 
and has a 50% chance of causing an infection at least once in a person’s lifetime.1 Although the 
body has the capability to clear HPV on its own, when this does not occur there are adverse 
physical manifestations that arise. One of the manifestations of HPV is genital/anogenital warts; 
this is the most common sexually transmitted disease and affects a large majority of the 
population. This type of infection is caused by a low-grade HPV with a high rate of disease 
regression, which rarely advance towards cancer.1 About 40 subtypes out of more than 120 HPV 
subtypes are directly linked to anogenital warts.2 These warts increase in size over time 
becoming increasingly visible and can interfere with everyday life if there is no treatment 
intervention. 
The number of people affected has been growing over the years and as it increases so 
does the financial burden. The number of new cases can range anywhere from 500,000-
1,000,000 per year. As of 2012, there are as many as 20 million infected in the United States, and 
this number continued to increase.2 As new patients seek treatment there is also an increase in 
office visits, follow-up visits, and trial and error of medication combination. Chesson et al. 
summarized that the overall cost of prevention and care of HPV in 2010 was $8 billion, of which 
$300 million was directed towards genital warts.3 Beyond treatment for established infections, 
HPV vaccines, including Gardasil and Cervarix, can be given to protect against this disease. In 
patients that are HPV naïve, Gardasil has shown to be 99 percent effective in genital wart 
prevention and long-term studies have shown that it doesn’t seem to have waning immunity.3  
When a person has been infected, the symptoms may not always be severe enough to 
seek treatment. Visible symptoms present 2-3 months after first contact2 and can include but 
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aren’t limited to itching, burning, tenderness, and/or discomfort. Warts can present as 
flat/sessile/lobular papules and can be symptomatic or asymptomatic.4 The treatment has become 
disproportionately centered around the removal of visible warts rather than the actual cure of the 
underlying cause. Consequently, there are no definitive treatments, but current therapies are 
individualized to each patient.2 Because of this method, reoccurrence is high and depending on 
the size and number of warts present, it may take several office visits to get this condition under 
control.5 Without an absolute cure, the rate of persons infected will continuously increase.  
There are two different approaches to the treatment of genital/anogenital warts: surgical 
and non-surgical.  Surgical therapies include cryotherapy, excision, electrosurgery, and laser 
ablation. Non-surgical methods include podophyllin resin, podophyllotoxin cream, interferons, 
ALA-PDT, trichloroacetic acid, topical photodynamic therapy using aminolevulinic acid, 
sinecatechins 15% ointment, and cryotherapy.  While there are many treatments that can halt the 
growth or reduce the chances of reoccurrence, the therapies available can be inadequate or have 
limitations that cannot treat the underlying cause. Cryotherapy alone has shown to be ineffective 
against latent lesions and limited to removal of visible lesions.6 Albeit some of these modalities 
only affect visible lesions, others have a stronger effect on latent infections or can reduce the 
amount of sessions needed for clearance. Although there are some benefits to using cryotherapy, 
the limitations from a single modality have caused the need for further research into combination 
treatments. Combination therapies have been demonstrated to affect latent lesions, can be used as 
at-home treatment, and have been shown to have an earlier onset of action.4,5,6 With so many 
possible methods for treatment, patients have a variety of options that can cater to their specific 
type of infection.  
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  As previously mentioned, genital/anogenital warts can have a negative impact on a 
person’s intimate life. Although the main concern is the visibility of the wart, accompanying 
symptoms such as itching, pain/bleeding with intercourse, and the possibility of warts in the 
mouth/throat when in contact with an infected person4 are reasons to look for an alternative 
treatment.  
OBJECTIVE 
The objective of this selective EBM review is to determine whether or not there is a 
greater statistically significant difference in the clearance or partial clearance of 
genital/anogenital warts when it comes to combination therapies that include cryotherapy vs 
cryotherapy alone. 
METHOD  
All sources were searched and selected from PubMed. The three studies used in this 
review were 3 randomized, single/double blinded and comparative studies comparing 
combination therapies that included cryotherapy vs. cryotherapy alone in the complete/partial 
clearance of genital/anogenital warts. The patient population consisted of males and females ages 
18 and above that had either anogenital or genital warts. The interventions included 
sinechatechins 15% ointment plus cryotherapy, podophyllotoxin plus cryotherapy, and 
photodynamic therapy plus cryotherapy. All these interventions were in comparison to the 
control group, cryotherapy. The outcomes of these EBM studies were focused around the overall 
level of clearance and partial clearance of warts. 
 The key words that were used in the selection of these articles through PubMed included: 
cryotherapy, genital warts, and anogenital warts. These peer-reviewed articles were published in 
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English and publication took place within the last 10 years. The selection was based on their 
applicability and how accurately they answered the question regarding the patient population. 
The statistics reported consisted of Chi-square, Fisher’s exact test, ANCOVA model, Cochran, 
and the Mantel-Haenszel test. A more descripted inclusion and exclusion criteria is explained 
below in Table 1.   
Table 1. Demographics and characteristics of included studies 
Study Type # of 
pts 
Age 
(yrs) 
Inclusion 
criteria 
Exclusion criteria W/D Interventions 
On, 
2014  
RCT 42 >18 2 or more 
clinically 
typical, 
visible warts; 
negative 
pregnancy 
tests and use 
of approved 
method of 
birth control 
throughout 
duration of 
study 
Hx of herpes 
genitalis, HIV, 
hepatitis B and C, hx 
of organ allograft, 
and/or internal warts 
requiring tx. Recent 
tx, within 90 days, 
or dermatologic 
procedures that 
could interfere with 
the evaluation of 
current tx 
9 Sinecatechins 
15% ointment 
plus 
cryotherapy vs 
cryotherapy 
Gilson, 
2009  
RCT 149 18-
70 
At least 2 
external 
anogenital 
warts that 
could be 
appropriately 
treated 
HIV positive, 
concurrent internal 
anogenital warts, 
warts > than 4 cm2 
13 Podophyllotoxin 
cream plus 
cryotherapy vs 
cryotherapy 
Mi, 
2011  
randomized 
clinical 
comparative 
study 
109 18-
54 
At least 3 
(max of 30) 
anogenital 
warts or one 
larger than 
0.5 cm (max: 
2 cm) 
Infected with other 
sexually transmitted 
ds, had 
immunosuppression, 
were pregnant or 
breast feeding, or 
had concurrent intra-
anal or intra-vaginal 
warts 
29 Photodynamic 
therapy plus 
cryotherapy vs 
cryotherapy 
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OUTCOMES MEASURED  
 The outcomes were patient oriented (POEMs) and were determined based on the 
reoccurrence of warts, and the comparison between complete vs. partial clearance. On et al., used 
chi-squared test to compare partial. Gilson et al., used observed data and last observation carried 
forward (LOCF) in patients that didn’t follow-up according to their schedule. Mi et al., used 
Cochran and the Mantel-Haenszel test to evaluate the recurrences of warts and number of 
completed responses.  
RESULTS  
All three studies tested methods that would decipher whether a combination therapy or 
cryotherapy alone would result in a better outcome in genital/anogenital warts. Each systematic 
review consisted of either a double-blind placebo-controlled study, a single-blinded randomized 
controlled study, or a randomized clinical comparative study. About 20% loss to follow up was 
experienced in the study consisting of podophyllotoxin cream plus cryotherapy. In the study 
including sinecatechins 15%, only 2 patients were lost to follow-up. In all three studies, all the 
patients were randomly placed into either the experimental or control group and all evaluators 
remained blinded during examination of the lesions. Adverse effects were limited to erythema, 
scaling, irritation, mild to moderate pain, hypopigmentation, soreness, and in no study did 
patients withdrawal due to severity of adverse effects.4,5,6 
 
 
 
 
 
 
 Burbano, Combination Therapies vs Cryotherapy in Treating Anogenital/Genital Warts 6 
Table 2. Treatment effect comparison in ITT population regarding partial clearance4 
 sinecatechins 15% 
ointment plus 
cryotherapy (n=21) 
Cryotherapy alone 
(n=21) 
*P-value 
 
Week 1 
n (%) cleared 
7 (33.3%) 6 (28.6%) p = 0.7385 
Week 9  
n (%) cleared 
15 (71.4%) 9 (42.9%) p = 0.0614 
Week 17 
n (%) cleared 
15 (71.4%) 11 (52.4%) p = 0.2037 
* p-values calculated using Chi squared 
On et al. conducted a study where 42 patients underwent cryotherapy treatment as a 
baseline and after one week two groups were divided between the experimental group, 
sinecatechins 15% ointment, and the control group, cryotherapy alone. Both groups had an 
average range of 8.3 – 9.8 lesions. Subjects were to have at least 2 or more visible warts and 
were expected to continue treatment for 17 weeks or until complete clearance of warts.4 On et 
al., defined complete clearance as having zero lesions and partial clearance was defined as 
having 50% reduction from baseline. At the end of week 17, the resulting p > 0.05 indicated the 
outcome regarding partial clearance was not statistically significant even though the trend 
favored the combination therapy. 
Table 3. Anogenital wart clearance; ITT analysis using LOCF5 
 Podophyllotoxin 
combination 
(n=70) 
Cryotherapy 
alone 
(n=70) 
Unadjusted OR 
(95% CI) 
------------- 
P-value 
 
Adjusted OR 
(95% CI) 
------------- 
P-value 
Week 4  
n (%) cleared 
42 (60.0) 32 (45.7) 1.78 (0.91 to 3.48) 
p = 0.09 
1.99 (0.91 to 4.36) 
p = 0.085 
Week 12  
n (%) cleared 
42 (60.0) 32 (45.7) 1.78 (0.91 to 3.48) 
p = 0.09 
1.94 (0.95 to 3.97) 
p = 0.069 
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Gilson et al. conducted a multicentre, randomized, double-blind, placebo-controlled study 
with patients stratified by sex and history of anogenital warts. Patients were divided into two 
groups of 70. The experimental group was composed of podophyllotoxin plus cryotherapy, and 
control group was composed of cryotherapy alone. The effectiveness of podophyllotoxin was 
investigated by percentage of clearance and exploratory analysis regarding wart history and wart 
type.5 There were two major endpoints, at 4 and 12 weeks, when studying podophyllotoxin 
cream plus cryotherapy. While the most research is evaluated by these two endpoints, there were 
still data collected until 24 weeks on a voluntary basis. Even though the overall clearance was 
higher (60%) with the combination therapy at both endpoints than cryotherapy alone (45.7%) it 
wasn’t enough to be considered statistically significant due to the p-value being greater than 5%. 
During the 4th week there was a higher clearance rate in patients that had warts before (p = .009) 
vs. those who have never had warts before although there was no significant finding between the 
two groups at the 12-week mark.5 Between the keratotic and non-keratotic warts, there was no 
difference in clearance at week 4 or 12. The adjusted odds ratio takes into account the baseline 
number and area of warts, history and treatment center.5  
Table 4. Difference in the clearance or partial clearance of anogenital/genital warts when it 
comes to combination therapies that include cryotherapy versus cryotherapy alone 
Study Control event rate 
(CER) 
Experimental 
event rate (EER) 
Absolute benefit 
increase (ABI) 
Numbers needed 
to treat (NNT) 
On et al. 
complete 
clearance 
.286 .286 0 N/A 
On et al. partial 
clearance 
.429 .714 .190 4 
Gilson et al. 
complete 
clearance 
.457 .600 0.143 7 
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On et al. study showed there is no increased therapeutic outcome in using the 
combination treatment over the monotherapy regarding complete clearance. This study also 
showed that for every 4 patients treated with sinecatechins plus cryotherapy, one more will have 
clearance of at least 50% than if treated with cryotherapy alone.  Gilson et al. showed that for 
every 7 patients treated with combination therapy, one more person will have overall clearance 
than if treated with cryotherapy alone. 
Table 5. Response rate in patients after 1 and 2 treatments of cryotherapy plus ALA-PDT or 
cryotherapy6  
 Cryotherapy plus ALA-PDT Cryotherapy plus placebo-
PDT 
Number of lesions in the anal 
area 
111 132 
Response rate after one 
treatment 
18.9% 18.2% 
Response rate after two 
treatments 
32.4% 32.6% 
Number of lesions in the 
external genitals 
137 111 
Response rate after one 
treatment 
73.7% 38.7% 
Response rate after two 
treatments 
94.2% 50.5% 
 
Mi et al. conducted a randomized clinical comparative study with 40 patients that 
received the combination of ALA-photodynamic therapy (PDT) plus cryotherapy and 40 patients 
that received cryotherapy alone. ALA-PDT disrupts the target cell by the build-up of ALA-
induced protoporphyrin IX in cells that are increasing in number.6 Mi et al. states based on the 
Pearson chi-squared test and the t-test there was no statistically significant differences in the 
initial number of warts between the experimental and the control group. Table 5 shows a higher 
response rate in the treatment of genital warts with the combination therapy and the response rate 
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of anogenital warts clearance is about the same with both, cryotherapy alone and the 
combination therapy. Table 5 shows that after multiple treatments the clearance is higher in 
genital warts with the combination of cryotherapy plus ALA-PDT and no statistically significant 
improvement in the treatment of anogenital warts. Anogenital warts resulted in a p>0.05 after 
both treatments and a p< 0.05 in external genital area after both treatments.6 The response rates 
of genital/anogenital warts regarding each treatment utilized is explained in tables 5. 
DISCUSSION 
Genital/anogenital warts is a sexually transmitted disease caused by HPV that infects the 
body through a break in the skin or the mucosa when there is skin-to-skin contact or mucosa-to-
mucosa contact.1 Cryotherapy has long been a common modality in the treatment of warts. 
Unfortunately, its limitations cause researchers to look for alternative treatments with better 
results. Ideal alternatives would treat the underlying condition. 
Each research study described several ways to increase accuracy in their results. 
Sinecatechins 15% ointment could have been better reviewed with a larger sample size. 
Outcomes could have been affected by participants practicing unsafe sex or they may have not 
reported all sexual partners.4 Gilson et al., also expressed a larger sample size could determine 
whether or not the effects of podophyllotoxin cream with cryotherapy was actually superior to 
cryotherapy alone. Factors that could’ve affected the outcome include patients being able to self-
asses and more patients in the podophyllotoxin combination arm stopped blinded study 
medication than in cryotherapy alone5. Mi et al. described a major limitation in the follow-up 
time. Follow-up was limited to 12 weeks and reoccurrence can be known to occur up to a year 
out.6 One of the limitations of the cryotherapy plus photodynamic therapy vs. cryotherapy is part 
of their exclusion criteria did not include those that were recently treated, if applicable. In two of 
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the studies, it was not made clear if they had tested for latent lesions. The study including 
podophyllotoxin cream plus cryotherapy was done in the United Kingdom and the combination 
was shown to have increase pain/soreness, so patient compliance would come into question.5 
Even with addressing these limitations there are always going to be uncontrollable factors such 
as patient compliance and reaction to medication that will inevitably cause meeting accuracy 
challenging. 
This EBM review was meant to evaluate 3 studies comparing different combination 
therapies that included cryotherapy vs. cryotherapy alone in the complete/partial clearance of 
genital/anogenital warts. Even though the results were favoring the combination therapy of 
sinecatechins 15% ointment plus cryotherapy, the data stated that the results were not statistically 
significant regarding partial clearance based on the p-value reported. In the review of 
podophyllotoxin cream plus cryotherapy, the results remained constant with slightly favorable 
results with the combination therapy, although not statistically significant even when adjusted for 
baseline number and area of warts, history and treatment center differences between the groups.5 
In the review of photodynamic therapy plus cryotherapy, the clinical results favored the 
combination therapy response rate over cryotherapy alone in the treatment of external genital 
warts after both treatments.   
CONCLUSION 
 All three studies have shown both combination therapies and cryotherapy alone have the 
capability of clearing anogenital/genital warts to an extent. The results in the study involving 
photodynamic therapy and cryotherapy favored the combination treatment. The studies involving 
sinecatechins 15% plus cryotherapy and podophyllotoxin plus cryotherapy favored cryotherapy 
alone. Although one portion of one of the studies favored combination therapy, there is not 
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enough evidence to ultimately conclude that combination therapies have a greater statistical 
difference in the clearance or partial clearance of anogenital/genital warts. Further research needs 
to be done since this is the first time the combination of photodynamic therapy plus cryotherapy 
has been studied and would benefit from expanding the exclusion criteria such as recent 
treatment and dermatological treatments that could interfere with results. All three of these 
combination therapies have not been properly evaluated before4,5,6 and with decreased limitations 
in future research, better outcomes can be achieved.    
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